|
CENPF expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.959410E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.231800E-01 |
| Normal-vs-Stage2 |
8.847200E-01 |
| Normal-vs-Stage3 |
2.444600E-01 |
| Normal-vs-Stage4 |
3.005900E-02 |
| Stage1-vs-Stage2 |
7.833900E-02 |
| Stage1-vs-Stage3 |
9.031600E-01 |
| Stage1-vs-Stage4 |
9.101800E-02 |
| Stage2-vs-Stage3 |
9.582400E-02 |
| Stage2-vs-Stage4 |
7.179900E-03 |
| Stage3-vs-Stage4 |
1.475760E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.207700E-02 |
| Normal-vs-AfricanAmerican |
4.014000E-01 |
| Normal-vs-Asian |
2.711400E-01 |
| Caucasian-vs-AfricanAmerican |
8.985000E-01 |
| Caucasian-vs-Asian |
7.412000E-01 |
| AfricanAmerican-vs-Asian |
9.448600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.154200E-01 |
| Normal-vs-Female |
2.610800E-01 |
| Male-vs-Female |
3.554000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.042950E-01 |
| Normal-vs-Age(41-60Yrs) |
8.443800E-01 |
| Normal-vs-Age(61-80Yrs) |
1.706020E-01 |
| Normal-vs-Age(81-100Yrs) |
1.452550E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.442900E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.787000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.354800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.144200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.483250E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.233400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.502000E-01 |
| Classical-VS-Follicular |
1.152600E-04 |
| Classical-VS-Other |
2.103600E-02 |
| Classical-VS-Normal |
4.085600E-02 |
| Tall-VS-Follicular |
2.730500E-02 |
| Tall-VS-Other |
5.388300E-02 |
| Tall-VS-Normal |
1.414010E-01 |
| Follicular-VS-Other |
9.781400E-01 |
| Follicular-VS-Normal |
6.653200E-01 |
| Other-VS-Normal |
7.241400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.568800E-01 |
| Normal-vs-N1 |
2.658800E-01 |
| N0-vs-N1 |
3.590400E-01 |
|
|
